Does UPADACITINIB Cause Hospitalisation? 550 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 550 reports of Hospitalisation have been filed in association with UPADACITINIB (Rinvoq). This represents 0.8% of all adverse event reports for UPADACITINIB.
550
Reports of Hospitalisation with UPADACITINIB
0.8%
of all UPADACITINIB reports
25
Deaths
421
Hospitalizations
How Dangerous Is Hospitalisation From UPADACITINIB?
Of the 550 reports, 25 (4.5%) resulted in death, 421 (76.5%) required hospitalization, and 7 (1.3%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 550 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which UPADACITINIB Alternatives Have Lower Hospitalisation Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL